Vedolizumab Beats Infliximab as Second-Line Therapy for Ulcerative ColitisMarch 7, 2025IBD & Intestinal Disorders
Subcutaneous Guselkumab Proves Efficacious for IBD in Two Studies: ASTRO and GRAVITIMarch 7, 2025IBD & Intestinal Disorders
Anxiety, Depression, and Insufficient Exercise Linked to IBD FlareMarch 6, 2025IBD & Intestinal Disorders
Machine-Learning Model Identifies Gut Biomarkers That May Help Diagnose IBD PatientsMarch 6, 2025IBD & Intestinal Disorders
Virtual Chromoendoscopy Beats Other Modalities at Neoplasia Detection in IBDMarch 4, 2025IBD & Intestinal DisordersGI OncologyEndoscopy
Not All Plant-based Diets Are Equal in IBD Risk MitigationFebruary 27, 2025IBD & Intestinal Disorders
Model May Predict Which UC Patients Risk RehospitalizationFebruary 26, 2025IBD & Intestinal Disorders
Choosing the Ideal Endoscopic Enteral Access Method: AGA Practice UpdateFebruary 25, 2025EndoscopyUpper GI Tract
Navigating Esophageal Dysfunction in Immune and Infectious Disorders: AGA Clinical Practice UpdateFebruary 20, 2025Upper GI Tract
